Neuromuscular dysfunction is prevalent in critically ill patients, is associated with worse
short-term outcomes, and is a determinant of long-term disability in intensive care unit …

More recently, it has been discovered that many critically ill patients develop new
neuromuscular disorders secondary to their critical illness following ICU admission. These …

In a retrospective one-year study, we documented respiratory failure or prolonged
neuromuscular blockade in eight of 65 patients with chronic renal failure who had received …

Neuromuscular disorders increasingly are recognized as a complication in patients in the
intensive care unit (ICU) and represent a common cause of prolonged ventilator …

Recent reports from around the world have demonstrated that some critically ill patients
remain profoundly weak for days to weeks after receiving a neuromuscular blocking agent in …

Nondepolarizing neuromuscular blocking agents (NNMBAs) are frequently administered to
patients in the intensive care unit (ICU). We conducted a retrospective study of patients in …

Recent literature suggests that the risk of prolonged neuromuscular blockade associated
with atracurium compared with other nondepolarizing neuromuscular blocking agents may …

We applied an activity-based costing methodology to determine the full cost of intensive care
service at a community hospital. a university hospital and a health maintenance organisation …

Antagonism of atracurium-induced neuromuscular blockade with neustigmine (one or two
doses of 2.5 mg) was compared, using electromyography, with spontaneous recovery. Two …

Generalized weakness in intensive care unit (ICU) patients is increasingly recognized as a
frequent complication and a common cause of prolonged ventilator dependency …